Sunday, January 24, 2021

Tag: Animal Health

PetVivo Holdings, Inc. (OTCQB: PETV”d”) Could make a great Acquisition Target

Petco Health and Wellness Company (NASDAQ: WOOF) launched its third IPO in Company history last Thursday, and this time, according to CNN Business, It’s taking...

PetVivo to become Listed with Benefits

Companies that trade on major exchanges have a far better chance of receiving coverage from independent research firms and investment banks, which will ultimately help drive market and investment activity in a particular stock. Most independent research firms and investment banks however do not provide coverage for companies trading on the OTC markets.

PetVivo advances its Up-list to NASDAQ

Animal Health, Animal Hospital, arthritis, Biotech, Biotechnology, coronavirus, CoronaVirus Cure, CoronaVirus Vaccine, COVID-19, covid19, Medical, Micro Cap Stocks, OTC Markets, OTC OTCQB, Small Cap Stocks

More than Just a Tigers Tale

PetVivo, Inc. (OTCQB: PETV), is the producer of “Kush”, which is a veterinarian-administered intraarticular injection for the treatment of osteoarthritis and other lameness issues in dogs and horses is intended to provide a lubricious cushion between the bones to reinforce cartilage. KUSH is scheduled for expanded commercial sales and the development of its proprietary mucoadhesive active agent delivery products.

The Anatomy of an Emerging Growth Biotech Stock

Petvivo currently has 17 products in its pipeline with its feature product being “Kush”, which is a veterinarian-administered intraarticular injection for the treatment of osteoarthritis and other lameness issues in dogs and horses is intended to provide a lubricious cushion between the bones to reinforce cartilage.

This Emerging Growth Biotech to Showcase Its Stuff

On Friday, shares broke resistance on record dollar volume which makes perfect sense as there are over 2 million equine owners in the US, many of which pay attention to this convention.

Is this Small Cap Biotech going to Uplist to NASDAQ?

Should it be a surprise that we learned just last week in the company’s 8-K that PetVivo Holdings, Inc. (OTCQB: PETV) adopted and approved an amended and restated “Charter of the Audit Committee”, “Charter of the Compensation Committee” and a “Nominating and Corporate Governance Committee Charter?” All of which are required by NASDAQ.

This Niche Biotech Company is paving the way with a Sponsored...

There is a niche biotech company called PetVivo, Holdings, Inc. (OTCQB: PETV). They are an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets. PetVivo is benefiting from trials on the human side with a lower barrier to approval for pets.

Covid-19 Vaccine is here. Where can you still find Value...

Have a look at PetVivo Holdings, Inc. (OTCQB: PETV). The stock has recently moved from a low of about $.20 per share up to over $1.60 on increasing volume.

Defensive Stocks to own before the Election

On August 14, Pet Vivo Holdings, Inc. (OTCQB: PETV) filed its quarterly report for the period ending June 30, 2020. In it, it showed current liabilities of $2.14 million. Since then, the company settled over $600,000.00 in liabilities which is reflected in recent 8K “material event” filings, as well as in its next quarterly report.